Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry F Vischer

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Journal of Medicinal Chemistry|May 15, 2013
Bispyrimidines as potent histamine H(4) receptor ligands: delineation of structure-activity relationships and detailed H(4) receptor binding modeHarald Engelhardt, Sabine Schultes, Chris de Graaf, et al.
Drug Discovery Today|December 26, 2012
Small and colorful stones make beautiful mosaics: fragment-based chemogenomicsChris de Graaf, Henry F Vischer, Gerdien E de Kloe, et al.
Journal of Medicinal Chemistry|November 2, 2019
4-(3-Aminoazetidin-1-yl)pyrimidin-2-amines as High-Affinity Non-imidazole Histamine H<sub>3</sub> Receptor Agonists with in Vivo Central Nervous System ActivityGábor Wágner, Tamara A M Mocking, Marta Arimont, et al.
Iscience|September 5, 2022
Optical control of the β<sub>2</sub>-adrenergic receptor with opto-prop-2: A <i>cis</i>-active azobenzene analog of propranololReggie Bosma, Nicola C Dijon, Yang Zheng, et al.
The Journal of Biological Chemistry|January 24, 2013
β-Arrestin recruitment and G protein signaling by the atypical human chemokine decoy receptor CCX-CKRAnne O Watts, Folkert Verkaar, Miranda M C van der Lee, et al.
Molecular Pharmacology|November 29, 2025
Inhibition of constitutive activity of the atypical chemokine receptor 3 by the small-molecule inverse agonist VUF16840Reggie Bosma, Desislava Nesheva, Merel Rijnsburger, et al.
Archiv Der Pharmazie|October 30, 2022
SAR exploration of the non-imidazole histamine H<sub>3</sub> receptor ligand ZEL-H16 reveals potent inverse agonismGábor Wágner, Tamara A M Mocking, Xiaoyuan Ma, et al.
The Journal of Biological Chemistry|August 28, 2013
Llama-derived single variable domains (nanobodies) directed against chemokine receptor CXCR7 reduce head and neck cancer cell growth in vivoDavid Maussang, Azra Mujić-Delić, Francis J Descamps, et al.
RSC Medicinal Chemistry|February 16, 2026
Leveraging fragment-based drug discovery to advance 3D scaffolds into potent ligands: application to the histamine H<sub>1</sub> receptorTom Dekker, Oscar P J van Linden, Herman D Lim, et al.
The Journal of Clinical Investigation|October 28, 2010
The cytomegalovirus-encoded chemokine receptor US28 promotes intestinal neoplasia in transgenic miceGerold Bongers, David Maussang, Luciana R Muniz, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Journal of Medicinal Chemistry|May 15, 2013
Bispyrimidines as potent histamine H(4) receptor ligands: delineation of structure-activity relationships and detailed H(4) receptor binding modeHarald Engelhardt, Sabine Schultes, Chris de Graaf, et al.
Drug Discovery Today|December 26, 2012
Small and colorful stones make beautiful mosaics: fragment-based chemogenomicsChris de Graaf, Henry F Vischer, Gerdien E de Kloe, et al.
Journal of Medicinal Chemistry|November 2, 2019
4-(3-Aminoazetidin-1-yl)pyrimidin-2-amines as High-Affinity Non-imidazole Histamine H<sub>3</sub> Receptor Agonists with in Vivo Central Nervous System ActivityGábor Wágner, Tamara A M Mocking, Marta Arimont, et al.
Iscience|September 5, 2022
Optical control of the β<sub>2</sub>-adrenergic receptor with opto-prop-2: A <i>cis</i>-active azobenzene analog of propranololReggie Bosma, Nicola C Dijon, Yang Zheng, et al.
The Journal of Biological Chemistry|January 24, 2013
β-Arrestin recruitment and G protein signaling by the atypical human chemokine decoy receptor CCX-CKRAnne O Watts, Folkert Verkaar, Miranda M C van der Lee, et al.
Molecular Pharmacology|November 29, 2025
Inhibition of constitutive activity of the atypical chemokine receptor 3 by the small-molecule inverse agonist VUF16840Reggie Bosma, Desislava Nesheva, Merel Rijnsburger, et al.
Archiv Der Pharmazie|October 30, 2022
SAR exploration of the non-imidazole histamine H<sub>3</sub> receptor ligand ZEL-H16 reveals potent inverse agonismGábor Wágner, Tamara A M Mocking, Xiaoyuan Ma, et al.
The Journal of Biological Chemistry|August 28, 2013
Llama-derived single variable domains (nanobodies) directed against chemokine receptor CXCR7 reduce head and neck cancer cell growth in vivoDavid Maussang, Azra Mujić-Delić, Francis J Descamps, et al.
RSC Medicinal Chemistry|February 16, 2026
Leveraging fragment-based drug discovery to advance 3D scaffolds into potent ligands: application to the histamine H<sub>1</sub> receptorTom Dekker, Oscar P J van Linden, Herman D Lim, et al.
The Journal of Clinical Investigation|October 28, 2010
The cytomegalovirus-encoded chemokine receptor US28 promotes intestinal neoplasia in transgenic miceGerold Bongers, David Maussang, Luciana R Muniz, et al.
Pageof 10